Intracoronary administration of a, thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm

Circulation Journal

Volumn 66, Issue 9, 2002, Pages 826-830

  Shozo, Sueda ^a   Hiroaki, Kohno ^a   Katsuji, Inoue ^a   Hiroshi, Fukuda ^a   Jun, Suzuki ^a   Kouki, Watanabe ^a   Naoto, Ochi ^b   Hiroyuki, Kawada ^b   Tadao, Uraoka ^b  

^a Saiseikai Saijo Hospital   (Japan)

^b Kita Medical Association Hospital   (Japan)

Author keywords

Acetylcholine; Spasm relief; Thromboxane A2 synthase inhibitor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLCHOLINE; OZAGREL; THROMBOXANE B2; THROMBOXANE SYNTHASE INHIBITOR; ENZYME INHIBITOR; METHACRYLIC ACID DERIVATIVE; THROMBOXANE SYNTHASE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY SPASM; CORONARY SINUS; DOSE RESPONSE; FEMALE; HUMAN; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PROVOCATION TEST; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION; THORAX PAIN; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ANTAGONISM; MIDDLE AGED; TREATMENT OUTCOME;

ACETYLCHOLINE; AGED; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; METHACRYLATES; MIDDLE AGED; THROMBOXANE-A SYNTHASE; TREATMENT OUTCOME;

EID: 0036727136     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.826     Document Type: Article

References (36)

1. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
2. Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid
3. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
4. Coronary arterial smooth muscle contraction by a substance released from platelets: Evidence that it is thromboxane A2
5. Coronary tone modulation: Formation and actions of prostaglandins, endoperoxides, and thromboxanes
6. Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus
7. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm
8. Multivessel coronary spasm in patients with variant angina: A study with intracoronary injection of acetylcholine
9. Formation of platelet aggregates after attacks of coronary spastic angina pectoris
10. Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm
11. Elevation of thromboxane B2 levels in patients with classic and variant angina pectoris
12. Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina
13. Thromboxane A2 in vasotonic angina pectoris: Evidence from direct measurements and inhibitor trials
14. Variant angina aggravated by aspirin
15. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease
16. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetyl-choline
17. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine
18. Usefulness of accelerated exercise following mild hyperventilation for the induction of coronary artery spasm: Comparison with an acetylcholine test
19. New non-invasive protocol for detection of coronary spastic angina with significant organic stenosis
20. Clinical characteristics of female patients with coronary spastic angina: Comparison with male patients
21. New combined spasm provocation test in patients with rest angina: Intracoronary injection of acetylcholine after intracoronary administration of ergonovine
22. Clinical characteristics and possible mechanism of paroxysmal atrial fibrillation induced by intracoronary injection of acetylcholine
23. The thrombolysis in myocardial infarction (TIMI) trial: Phase I findings
24. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular surgery, American Heart Association
25. Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism
26. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart
27. Exercise-induced angina provoked by aspirin administration in patients with variant angina
28. Histamine-induced spasm not significantly modulated by prostanoids in a swine model of coronary artery spasm
29. Effects of intravenous prostacyclin in variant angina
30. Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina
31. Prostacyclin for acute coronary insufficiency
32. Thromboxne A2 as an enhancing factor of coronary vasospasticity in variant angina
33. Role of endothelium in responses of vascular smooth muscle
34. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
35. The endothelium in acute coronary syndromes
36. A possible role of thromboxane A2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral arteries